Introduction We present international consensus recommendations for improving diagnosis,
management and treatment access in multiple sclerosis (MS). Our vision is that these will be …

Background Cost-of-illness (COI) studies of Multiple Sclerosis (MS) are vital components for
describing the economic burden of MS, and are frequently used in model studies of …

Background Multiple sclerosis (MS) often leads to severe neurological disability and a
serious decline in quality of life. The ideal target of disease‐modifying therapy for MS is to …

Background Multiple sclerosis has both high healthcare and social impacts. Objective The
purpose of this article is to analyse the available literature describing the economic burden …

Background Although the economic burden of multiple sclerosis (MS) in high-income
countries (HICs) has been extensively studied, information on the costs of MS in low-and …

Introduction The severity of relapses varies in multiple sclerosis (MS) and may lead to a
differential cost burden. This study aimed to characterize the direct healthcare costs …

Objective: Although multiple sclerosis (MS) is one of the most common causes of non-
traumatic disability among young adults, no published data on its economic and health …

Background Multiple sclerosis (MS) is prevalent among working age individuals (20–60
years), leading to high burden on work productivity. Few data are available about the …

Introduction In light of the increasing number of economic burden studies and heterogeneity
in methodology and reporting standards, there is a need for robust evidence synthesis on an …

Objective Multiple sclerosis is a complex neurological disease which can cause impairment
in a range of aspects of an individual's life. It often requires a degree of adjustment and peer …